Malignant Oropharyngeal Neoplasm — Trials

Malignant Oropharyngeal Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

461 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 143
Recruiting: 77
Ph III recruiting: 7
Growth YoY: −7.7%
Industry share: 6%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (67)

clinicaltrialsPublishedShowing 51–58 of 58 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03383094	Chemoradiation vs Immunotherapy and Radiation for Head and Neck Cancer	active not recruiting	Phase 2	126	Loren Mell, MDOTHER	1	Oct 7, 2025	clinicaltrials
NCT02984410	Study Assessing The "Best of" Radiotherapy vs the "Best of" Surgery in Patients With Oropharyngeal Carcinoma(Best Of)	active not recruiting	N/A	112	European Organisation for Research and Treatment of Cancer - EORTCNETWORK	8	Aug 14, 2025